Alessandro Dal Maso

6PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 21, 2025
MAPK Pathway-Activating Alteration and Immunotherapy Efficacy in Squamous Cell Lung Carcinoma: Results from the Randomized, Prospective SQUINT Trial.

Federico Cappuzzo, Biagio Ricciuti, Angelo Delmonte

|Mar 23, 2024
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World.

Giulia Pasello, Martina Lorenzi, Daniela Scattolin

|Aug 21, 2023
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting.

Laura Bonanno, Martina Lorenzi, Davide Massa

|Nov 26, 2022
The Multidisciplinary Approach in Stage III Non-Small Cell Lung Cancer over Ten Years: From Radiation Therapy Optimisation to Innovative Systemic Treatments.

Alessandra Ferro, Matteo Sepulcri, Marco Schiavon

|May 14, 2021
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines.

Alessandro Dal Maso, Martina Lorenzi, Alessandra Ferro

|May 28, 2020
Novel Nuclear Medicine Imaging Applications in Immuno-Oncology.

Stefano Frega, Alessandro Dal Maso, Giulia Pasello

Pageof 1

Frequent Collaborators

4 joint publications

Laura Bonanno

3 joint publications

Giulia Pasello

3 joint publications

Sara Pilotto

3 joint publications

Alessandra Ferro